http://orcid.org/0000-0002-9541-1405
Figures
Abstract
Wolfram syndrome (WS), caused by loss-of-function mutations in the Wolfram syndrome 1 gene (WFS1), is characterized by juvenile-onset diabetes mellitus, bilateral optic atrophy, and a wide spectrum of neurological and psychiatric manifestations. WFS1 encodes an endoplasmic reticulum (ER)-resident transmembrane protein, and mutations in this gene lead to pancreatic β-cell death induced by high levels of ER stress. However, the mechanisms underlying neurodegeneration caused by WFS1 deficiency remain elusive. Here, we investigated the role of WFS1 in the maintenance of neuronal integrity in vivo by knocking down the expression of wfs1, the Drosophila homolog of WFS1, in the central nervous system. Neuronal knockdown of wfs1 caused age-dependent behavioral deficits and neurodegeneration in the fly brain. Knockdown of wfs1 in neurons and glial cells resulted in premature death and significantly exacerbated behavioral deficits in flies, suggesting that wfs1 has important functions in both cell types. Although wfs1 knockdown alone did not promote ER stress, it increased the susceptibility to oxidative stress-, excitotoxicity- or tauopathy-induced behavioral deficits, and neurodegeneration. The glutamate release inhibitor riluzole significantly suppressed premature death phenotypes induced by neuronal and glial knockdown of wfs1. This study highlights the protective role of wfs1 against age-associated neurodegeneration and furthers our understanding of potential disease-modifying factors that determine susceptibility and resilience to age-associated neurodegenerative diseases.
Author summary
Wolfram syndrome (WS), a neurodegenerative disorder with an autosomal recessive inheritance pattern, has a variable clinical presentation that includes diabetes mellitus, optic atrophy, and a wide spectrum of neurological and psychiatric manifestations. Homozygous mutations in WFS1 are causative for WS. The prognosis of WS is poor, and most patients die prematurely with respiratory failure due to brain stem atrophy. However, the mechanisms underlying the neurological manifestations of WS remain elusive. In this study, we used the fruit fly Drosophila to examine the neurological features of WS by generating genetically modified flies harboring knockdown of wfs1, the fly homolog of WFS1, in the central nervous system. These flies developed age-dependent behavioral deficits, neurodegeneration and premature death. wfs1-deficient flies were vulnerable to various age-related stressors such as oxidative stress and excitotoxicity, and to neurodegeneration caused by Alzheimer’s disease-related toxic proteins. The premature death phenotype in wfs1-deficient flies was ameliorated by administration of riluzole, which inhibits glutamate-induced excitotoxicity. This study provides insight into the mechanisms underlying neurodegeneration not only in WS, but also in age-associated neurodegenerative diseases such as Alzheimer’s disease.
Citation: Sakakibara Y, Sekiya M, Fujisaki N, Quan X, Iijima KM (2018) Knockdown of wfs1, a fly homolog of Wolfram syndrome 1, in the nervous system increases susceptibility to age- and stress-induced neuronal dysfunction and degeneration in Drosophila. PLoS Genet 14(1): e1007196. https://doi.org/10.1371/journal.pgen.1007196
Editor: Bingwei Lu, Stanford University School of Medicine, UNITED STATES
Received: December 1, 2016; Accepted: January 9, 2018; Published: January 22, 2018
Copyright: © 2018 Sakakibara et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: This work was supported by grants from the Research Funding for Longevity Sciences from National Center for Geriatrics and Gerontology Japan, grant number 28-26, Japan Society for the Promotion of Science KAKENHI (JP), grant number JP16K08637, and Takeda Science Foundation (JP) to KMI, and Japan Society for the Promotion of Science KAKENHI (JP), grant number 26870921 to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Wolfram syndrome (WS; OMIM 222300) is a progressive neurodegenerative disorder characterized by an autosomal recessive inheritance pattern [1]. The clinical manifestations of WS are highly variable and include diabetes insipidus, diabetes mellitus, optic atrophy, and deafness, known as the DIDMOAD syndrome [1]. Juvenile-onset diabetes mellitus and bilateral optic atrophy, which usually emerge by the second decade of life, are the minimal criteria for diagnosis [2,3].
Molecular genetic studies show that 90% of WS patients carry a loss-of-function mutation in the WFS1 gene [4,5], which encodes an endoplasmic reticulum (ER)-resident transmembrane protein [6,7]. Although the WFS1 protein lacks a distinct functional domain structure, a growing body of evidence indicates that WFS1 regulates the cellular response to ER stress [8–12] as well as intracellular Ca2+ homeostasis [13–15]. WFS1 deletion in mice leads to progressive loss of pancreatic β cells and impaired glucose tolerance induced by high levels of ER stress and apoptosis in β cells [11,16,17]. Thus, the pathogenesis of WS involves chronic ER stress in pancreatic β cells leading to diabetes mellitus [8–11], and WS is considered as a prototype of ER disease [8,13,16]. Common variants in WFS1 are also associated with the risk of type 2 diabetes [18].
In addition to these cardinal features of the disorder, WS patients exhibit a wide spectrum of neurological and psychiatric manifestations including peripheral neuropathy, epilepsy, cognitive decline, and anxiety [19,20]. Magnetic resonance imaging studies show diffuse and widespread atrophy throughout the brain [21–23], which partly correlates with the major neurological features of the disorder. The prognosis of WS is poor, and most patients die prematurely with severe neurological disabilities at a median age of 30 years, usually from respiratory failure resulting from brain stem atrophy [1,24,25]. Carriers of WFS1 mutations who are not affected by WS have a 26-fold higher likelihood of psychiatric hospitalization, primarily for depression [26]. Consistent with this, heterozygosity for WFS1 gene mutations, which is present in up to 1% of the general population, is a significant cause of psychiatric illness in the general population [26–28]. Therefore, elucidating the mechanisms underlying the effects of WFS1 mutations will advance our understanding of neurological and neurodegenerative diseases and lead to the development of therapeutic strategies to halt the progression of WFS1-related disorders.
Wfs1 knockout mice recapitulate several aspects of the neurological manifestations of WS, including impaired behavioral adaptation to stress [29,30], stress-induced depressive behavior [31], and alterations in visual function [32]. A recent study used a rat model to demonstrate that deletion of exon 5 of the Wfs1 gene, which results in the loss of 27 amino acids from the Wfs1 protein, caused insulin-dependent diabetes, optic nerve atrophy, and medullary degeneration [33]. However, the mechanisms underlying the neurological manifestations of WFS1 deficiency remain elusive.
In this study, we used Drosophila as a genetic model to analyze the effects of WFS1 deficiency on neuronal integrity during aging. According to the DIOPT (DRSC Integrative Ortholog Prediction Tool), Drosophila wfs1 (CG4917) is the best homolog of human WFS1 proteins (DIOPT score 10); wfs1 and WFS1 exhibit 25% identity and 42% similarity in primary amino acid sequence, are similar in size (853 and 890 amino acids, respectively), and have the same nine predicted transmembrane helices (TMHMM Server v. 2.0). Analysis of wfs1 mutant flies and flies with RNAi-mediated knockdown of wfs1 in the central nervous system showed that wfs1 deficiency increased susceptibility to age- and stress-induced neuronal dysfunction and degeneration. Our results also suggest that imbalance in neural activity and vulnerability to oxidative stress are involved in this process.
Results
Neuronal knockdown of wfs1, a fly homolog of WFS1, causes behavioral deficits and neurodegeneration
In rodent brains, the mRNA levels of Wfs1 increase during aging [34]. Quantitative PCR (qPCR) analysis showed that the mRNA levels of Drosophila wfs1, a fly homolog of human WFS1, increased with aging in fly brains (Fig 1A). These results indicated that WFS1 may play an evolutionarily conserved role in maintaining neuronal integrity during aging.
(A) mRNA expression levels of wfs1 were increased upon aging in the fly brains, as determined by qRT-PCR. n = 4, ***p < 0.001 by Student’s t-test. (B) A schematic diagram of the wfs1 RNAi target sites and insertion sites of MiMIC/PiggyBac for wfs1 mutant lines. (C) mRNA levels of wfs1 in heads of flies carrying the RNAi transgene targeting wfs1 were analyzed by qRT-PCR. n = 4, ***p < 0.001 by Student’s t-test. (D) Knockdown of wfs1 in neurons induced age-dependent locomotor deficits as revealed by climbing assay. Flies carrying the mcherry RNAi transgene did not induce the age-dependent locomotor deficits. Average percentages of flies that climbed to the top (white), climbed to the middle (light gray), or stayed at the bottom (dark gray) of the vials. Percentages of flies that stayed at the bottom were subjected to statistical analyses. n = 7 independent experiments, *p < 0.05, **p < 0.01 and ***p < 0.001 by Student’s t-test. (E) Neuronal knockdown of wfs1 caused age-dependent neurodegeneration in the central neuropil or optic lobes of fly brain. Representative images show the central neuropil and optic lobe in paraffin-embedded brain section with hematoxylin and eosin (HE) staining from 60-day-old flies. Scale bars: 200 μm. Percentages of vacuole areas (indicated by arrowheads in the images) in central neuropil or optic lobes from 20-, 30-, and 60-day-old flies were analyzed. n = 8–12 hemispheres, *p < 0.05 and ***p < 0.001 by Student’s t-test. (F) Neuronal knockdown of wfs1 shortened the lifespan (n = 182, wfs1 RNAi group or 358, control group). The lifespans of flies were determined by Kaplan-Meier survival analysis with log-rank test and statistical significance was indicated in the figure. Genotypes and ages of flies are described in S1 Table.
To elucidate the roles of WFS1 in neuronal integrity during aging in Drosophila, we knocked down wfs1 in the central nervous system. The GAL4/UAS system was used to induce neuron-specific knockdown of wfs1 by crossing transgenic flies carrying RNAi targeting wfs1 (TRiP RNAi, Fig 1B) with flies carrying the pan-neuronal elav-GAL4 driver. qPCR confirmed that neuron-specific expression of wfs1 RNAi significantly reduced wfs1 mRNA levels in fly brains (Fig 1C).
To determine whether neuron-specific wfs1 knockdown caused age-dependent neuronal dysfunction, locomotor ability was assessed using the forced climbing assay. Neuronal knockdown of wfs1 induced age-dependent locomotor deficits starting at 21 days of age (Fig 1D), suggesting that wfs1 deficiency in neurons is sufficient to induce age-dependent behavioral deficits. In Drosophila, brain vacuolation is a morphological hallmark of neurodegeneration [35]. Neuronal knockdown of wfs1 significantly increased the age-dependent appearance of vacuoles in the central neuropil and optic lobes of the fly brain (Fig 1E) and slightly, but significantly, shortened the lifespan of the flies (Fig 1F).
To minimize possible off-target effects of RNAi, the climbing assay was performed in an independent line of transgenic flies carrying RNAi targeting a different region of wfs1 (Fig 1B, RNAi). Although the knockdown efficiency of this RNAi line was weaker (S1A Fig), the age-dependent decline in climbing ability was also observed in these wfs1 knockdown flies (S1B Fig).
Knockdown of wfs1 in both neurons and glial cells significantly shortens the lifespan of flies and exaggerates behavioral deficits and neurodegeneration
In mammals, the WFS1 protein is mainly expressed in neurons, although expression is also observed in some glial cell types. In the context of optic atrophy, several anatomical studies reported expression of WFS1 in optic nerve astrocytes [36,37], suggesting that failure of the surrounding glial cells has detrimental effects resulting in optic nerve degeneration. In Drosophila, the MODENCODE database (http://www.modencode.org/) [38] indicates that wfs1 is expressed ubiquitously in all stages of flies. However, the physiological functions of WFS1/wfs1 in glial cells remain unclear.
To determine the role of wfs1 in glial cells in maintaining neuronal integrity in flies, we knocked down the expression of wfs1 in neurons and glial cells using the elav-GAL4 and pan-glial Repo-GAL4 drivers. Knockdown of wfs1 in neurons and glial cells exaggerated age-dependent locomotor deficits (Fig 2A) relative to those observed in flies with wfs1 knockdown in neurons (Fig 1D) or glial cells (Fig 2D). By contrast, the severity of neurodegeneration was modestly enhanced in flies with knockdown of wfs1 in both neurons and glial cells (Fig 2B) relative to that in flies with wfs1 knockdown only in neurons (Fig 1E, 30 days) or glial cells (Fig 2E). Flies with knockdown of wfs1 in both neurons and glial cells had a dramatically shorter lifespan (Fig 2C) than those with wfs1 knockdown only in neurons (Fig 1F) or glial cells (Fig 2F). Similar effects of neuronal and glial knockdown of wfs1 on lifespan were obtained with an independent RNAi line (S1C Fig). These results suggest that wfs1 in neurons and glial cells act in concert to maintain neural function and integrity during aging in flies.
(A) Knockdown of wfs1 in both neurons and glial cells, (D) but not in glial cells alone, caused age-dependent locomotor deficits as revealed by climbing assay. Average percentages of flies that climbed to the top (white), climbed to the middle (light gray), or stayed at the bottom (dark gray) of the vials. Percentages of flies that stayed at the bottom were subjected to statistical analyses. n = 3–5 independent experiments, *p < 0.05 by Student’s t-test. (B) Knockdown of wfs1 in both neurons and glial cells, (E) but not in glial cells alone, caused neurodegeneration in the central neuropil or optic lobes of fly brain. Representative images show the central neuropil and optic lobe in paraffin-embedded brain section with hematoxylin and eosin (HE) staining from 30-day-old flies. Scale bars: 200 μm. Percentages of vacuole areas (indicated by arrowheads in the images) in central neuropil or optic lobes are shown. n = 14–19 hemispheres, ***p < 0.001 by Student’s t-test. (C) Knockdown of wfs1 in both neurons and glial cells significantly shortened lifespan of flies (n = 199, wfs1 RNAi group or 331, control group). (F) Knockdown of wfs1 in glial cells did not affect lifespan up to 30 days (n = 114, wfs1 RNAi group or 139, control group). The lifespans of flies were determined by Kaplan-Meier survival analysis with log-rank test and statistical significance was indicated in the figure. Genotypes and ages of flies are described in S1 Table.
Mutations in the wfs1 gene cause behavioral deficits and neurodegeneration and shorten the lifespan of flies
We next characterized the phenotypes of wfs1 mutant flies, a MiMIC line (Fig 1B), and PiggyBac lines (e03461 and LL07290, Fig 1B). In a line with a PiggyBac e03461 insertion located in the 5′ upstream of the wfs1 gene (Fig 1B), qRT-PCR analysis revealed that the mRNA levels of wfs1 were not altered (S2A Fig), and this line was excluded from further characterization. In a line with a PiggyBac LL07290 insertion located 5′ upstream of the wfs1 gene close to the start codon (Fig 1B), the mRNA levels of wfs1 were significantly reduced (by approximately 60%), whereas those of the adjacent gene, Nup133, were dramatically increased (S2B Fig). Phenotypic analysis showed age-dependent locomotor deficits (S2C Fig) and premature death (S2D Fig) in these flies.
In a MiMIC insertion located in the last exon of the wfs1 gene (Fig 1B), DNA sequence analysis around the putative insertion sites showed that the wfs1 protein (852 amino acids length) ended at amino acid position 592 and was flanked by four amino acids derived from the MiMIC constructs (S3 Fig). The mRNA expression levels were not altered in these flies (Fig 3A). The MiMIC flies were therefore expected to express a C-terminally truncated version of the wfs1 protein (Fig 3B), which may act as a partial loss-of-function and/or gain-of-function mutation. These flies showed age-dependent locomotor defects (Fig 3C) and neurodegeneration (Fig 3D). Taken together, these data suggest that the neurological phenotypes induced by neuronal knockdown of wfs1 were present in both MiMIC and PiggyBac insertion lines.
(A) mRNA levels of wfs1 in heads of flies carrying homozygous mutations of wfs1 with MiMIC insertion (wfs1MI14041/MI14041) were analyzed by qRT-PCR. n = 4. (B) Schematic diagrams of wild-type wfs1 protein (wfs1) and C-terminally truncated wfs1 protein by MiMIC insertion (wfs1MI14041). (C) The wfs1 mutant flies with MiMIC insertion induced age-dependent locomotor deficits as revealed by climbing assay. Average percentages of flies that climbed to the top (white), climbed to the middle (light gray), or stayed at the bottom (dark gray) of the vials. Percentages of flies that stayed at the bottom were subjected to statistical analyses. n = 3 independent experiments, *p < 0.05 and **p < 0.01 by Student’s t-test. (D) Homozygous mutations of wfs1 with MiMIC insertion caused age-dependent neurodegeneration in the optic lobes of fly brain. Representative images show the optic lobe in paraffin-embedded brain section with hematoxylin and eosin (HE) staining from 50-day-old flies. Scale bars: 200 μm. Percentages of vacuole areas (indicated by arrowheads in the images) in the optic lobes from 35- and 50-day-old flies were analyzed. n = 22–24 hemispheres, ***p < 0.001 by Student’s t-test. Genotypes and ages of flies are described in S1 Table.
Neuronal knockdown of wfs1 alone does not induce ER stress, mitochondrial dysfunction, or lysosome/autophagy defects in fly brains
In mammals, the WFS1 protein mainly localizes to the ER [39] and secretory vesicles [40], and to a lesser extent to mitochondria [40,41]. To examine the cellular localization of wfs1 in Drosophila cells, the wfs1 protein was tagged with HA at the C-terminus and expressed in Drosophila S2 cells. Immunostaining with anti-HA antibody revealed that, although overlaps between wfs1 proteins and KEDL signals were weak, they partially overlapped with Concanavalin A (ConA) staining, another ER marker as well as Mitotracker signals (S4 Fig).
WFS1 expression is induced to regulate the cellular response against ER stress in mammalian cells [8–12]. We asked whether this mechanism is evolutionally conserved in Drosophila. Of the three main branches of the mammalian unfolded protein response (UPR), the PERK and IRE1/XBP1 pathways are well conserved in Drosophila [42]; in flies, the Ire1-dependent splicing of Xbp1 mRNA generates the active Xbp1 isoform Xbp1-RB. To induce ER stress in fly brain neurons, we expressed misfolding prone amyloid-β42 peptides (Aβ42) in the ER [43]. We found that mRNA expression levels of wfs1 along with other ER stress marker genes, including Xbp1-RB, PEK (fly ortholog of PEK) and the ER chaperone Hsc70-3, which is among the downstream targets of Xbp1-RB, were significantly increased in fly heads expressing Aβ42 (S5 Fig). These results suggest that fly cells are capable of inducing wfs1 expression upon ER stress in vivo.
WFS1 deficiency leads to ER stress in pancreatic β-cell lines such as INS-1 [8,13], pancreatic β cells from Wfs1-deficient mice [11,16], or WS patients [10]. By contrast, activation of the UPR is not observed in non-pancreatic tissues including the brains of Wfs1 knockout mice [11]. To determine whether knockdown of wfs1 in the nervous system induced ER stress in fly brains, the expression of UPR-related genes was analyzed. The levels of mRNAs encoding Xbp1-RB, PEK, and Hsc70-3 in aged fly brains were slightly lower in neuronal or neuronal and glial wfs1 knockdown flies than in the controls (Fig 4A and 4B). Similar results were obtained in wfs1 mutant flies (Fig 4C). These results suggest that global activation of ER stress in fly brains is not the primary cause of the neurodegenerative phenotypes induced by wfs1 deficiency.
(A) Neuronal (elav), (B) neuronal and glial (elav-Repo) knockdown of wfs1 or (C) wfs1 mutant with MiMIC insertion (wfs1MI14041/MI14041) did not increase mRNA levels of Xbp1-RB, PEK and Hsc70-3 in fly brains, as determined by qRT-PCR. n = 4, *p < 0.05 and ***p < 0.001 by Student’s t-test. Genotypes and ages of flies are described in S1 Table.
Because of the syndromic similarities of many clinical features between WS and mitochondrial disorders [44], the pathophysiology of WS has been attributed to mitochondrial dysfunction and mitochondrial DNA (mtDNA) defects [45–48]. A recent study using primary cultured neurons demonstrated that WFS1 deficiency alters Ca2+ homeostasis in the ER and promotes mitophagy, leading to alterations in mitochondrial distribution and dynamics, reductions in ATP levels, and retardation of neuronal development [49]. These reports suggest that mitochondrial defects also contribute to neurodegeneration caused by WFS1 deficiency.
We investigated whether wfs1 deficiency would induce severe mitochondrial dysfunction in fly brains. The results showed that total ATP content did not differ significantly between control and wfs1 knockdown brains (S6A Fig). In addition, wfs1 deficiency did not dramatically alter the mRNA expression levels of genes involved in mitochondrial fission and fusion, including Marf, Opa1, Fis1, and Drp1 (S6B Fig), or the levels of mitochondrial-resident proteins, including VDAC1, NDUFS3, and MnSOD (S6C Fig). To determine whether neuronal knockdown of wfs1 affected mitochondrial distribution in fly brains, the mitochondrial marker mito-GFP was expressed in the mushroom body structures of the fly brain, where its distribution in the cell body, dendrites, and axons of mushroom body neurons could be easily distinguished and quantified (S6D Fig). The results showed that wfs1 deficiency did not significantly disrupt mito-GFP distribution in mushroom body neurons (S6E Fig). Finally, assessment of possible genetic interactions between wfs1 and Opa1 showed that mutation of Opa1 did not exacerbate the age-dependent neuronal dysfunction caused by wfs1 deficiency (S6F Fig).
To determine whether neuronal knockdown of wfs1 affects autophagy in aged fly brains, the levels of the ref(2)P protein and the Atg8-II/Atg8-I ratio were measured. If autophagy were compromised, ref(2)P levels and the Atg8-II/Atg8-I ratio would increase. There were no significant changes in the levels of ref(2)P or the Atg8-II/Atg8-I ratio in wfs1-knockdown flies, suggesting that autophagy efflux is not compromised by wfs1 knockdown (S7 Fig).
Taken together, these results indicated that wfs1 deficiency did not induce severe defects in mitochondrial and autophagy functions in fly brains.
Oxidative stress induces wfs1 expression, and neuronal knockdown of wfs1 increases vulnerability to oxidative stress
The results described in the past sections suggested that wfs1 deficiency by itself did not cause severe cellular dysfunction directly leading to neurodegeneration in fly brains. Since age-dependent neurodegeneration often involves oxidative stress, we first examined whether wfs1 plays a role in the oxidative stress response in flies. Exposure of flies to hydrogen peroxide (H2O2) significantly increased the mRNA levels of wfs1 in fly brains (Fig 5A), and neuronal knockdown of wfs1 significantly reduced the survival of flies under oxidative stress conditions (Fig 5B), suggesting that wfs1 plays a protective role against oxidative stress. We next examined whether wfs1 deficiency by itself was sufficient to induce an oxidative stress response under normal conditions. Despite small increases or decreases in the mRNA expression levels of oxidative stress-related genes, neuronal knockdown of wfs1 did not induce a severe oxidative stress response in fly brains (Fig 5C). Taken together, these results suggest that wfs1 deficiency in neurons increases the vulnerability to oxidative stress in flies.
(A) mRNA levels of wfs1 were induced by hydrogen peroxide (H2O2) exposure in fly brains, as determined by qRT-PCR. n = 4, ***p < 0.001 by Student’s t-test. (B) Neuronal knockdown of wfs1 significantly reduced survival time after H2O2 exposure compared with that of flies with mcherry RNAi. The survival rates of flies with H2O2 exposure were determined by Kaplan-Meier survival analysis with log-rank test and statistical significance was indicated in the figure (left panel) (n = 29, mcherry RNAi with 10% sucrose only, n = 26, wfs1 RNAi with 10% sucrose only, n = 236, mcherry RNAi with H2O2 exposure, n = 171, wfs1 RNAi with H2O2 exposure). Average survival time of wfs1 knockdown flies with H2O2 exposure was significantly reduced (right panel). ***p <0.001 by Student’s t-test. (C) The mRNA levels of genes related to oxidative stress responses in 29-day-old fly brains with wfs1 RNAi or mcherry RNAi were determined by qRT-PCR. n = 4, *p < 0.05, **p < 0.01 and ***p < 0.001 by Student’s t-test. Genotypes and ages of flies are described in S1 Table.
Heterozygous mutation in Eaat1, a glial high-affinity glutamate transporter, significantly worsens the behavioral deficits caused by wfs1 deficiency
The brain damage that occurs after ischemic stroke and in some neurodegenerative disorders is partially due to excessive quantities of extracellular glutamate and the concomitant overactivation of glutamate receptors, leading to excitotoxicity [50,51]. Extracellular glutamate levels are tightly regulated to enable the precise control of neurotransmission at glutamatergic synapses while preventing neuronal cell death. WS patients frequently develop diverse neurological complications including epilepsy [19]. In a rat model of epilepsy induced by kainic acid toxicity, Wfs1 mRNA levels are markedly reduced in the hippocampal CA3 region [52]. Wfs1 mRNA levels are elevated in aged rodent brains [34], and this increase is reversed by treatment with riluzole, a drug that inhibits glutamate release. Taken together, these findings suggest a potential link between aging, neuronal excitability, and wfs1 function in the brain.
Flies with knockdown of wfs1 in the nervous system exhibited a high frequency of supine behavior and a longer time to right from this position when the flies were tapped down to the bottom of the vials. The righting reflex assay [53] showed that flies with neuronal or both neuronal and glial knockdown of wfs1 (Fig 6A) and wfs1 mutant flies (Fig 6B) required a significantly longer time to right from the supine position. Since the supine behavior is induced by altered GABAergic activity [53], the mRNA expression levels of genes related to synaptic activities were examined, focusing on GABAergic and glutamatergic systems. The mRNA levels of seven out of eight genes encoding GABA receptors, except for Grd, a fly ortholog of GABA-A receptor α subunit, were not altered by neuronal and glial knockdown of wfs1, whereas the mRNA levels of Eaat1, a single high-affinity glutamate transporter expressed in glial cells, were significantly decreased in wfs1 knockdown flies (Fig 6C). We also found that the neuronal knockdown of wfs1 was sufficient to reduce mRNA expression levels of Eaat1 in fly heads (Fig 6D). These results suggest that neuronal knockdown of wfs1 down-regulates Eaat1 levels in glial cells in a cell non-autonomous manner and this may cause an imbalance in neural activity in flies.
(A) Flies with neuronal (elav), neuronal and glial (elav-Repo) knockdown of wfs1 or (B) wfs1 mutant with PiggyBac insertion (wfs1LL07290/LL07290) required longer time to complete righting reflex than control flies. n = 10–26, **p < 0.01 and ***p < 0.001 by Mann-Whitney U-test. (C) The mRNA levels of genes related to synaptic activities with focus on GABAergic as well as glutamatergic systems in fly brains with neuronal and glial knockdown of wfs1 were determined by qRT-PCR. n = 4, *p < 0.05 by Student’s t-test. (D) The mRNA level of Eaat1 in fly brains with neuronal knockdown of wfs1 was determined by qRT-PCR. n = 4, *p < 0.05 by Student’s t-test. (E) Heterozygous mutation in Eaat1 did not induce locomotor defects in aged flies (left panel). In the wfs1 knockdown background, heterozygous mutation in Eaat1 caused locomotor deficits (right panel) as revealed by climbing assay. Average percentages of flies that climbed to the top (white), climbed to the middle (light gray), or stayed at the bottom (dark gray) of the vials. Percentage of flies that stayed at the bottom were subjected to statistical analyses. n = 4 independent experiments. n = 5, *p < 0.05 by Student’s t-test. (F) A heterozygous mutation in Eaat1 induced ER stress responses in wfs1 knockdown background, but not in control background. The mRNA levels of Xbp1-RB, PEK and Hsc70-3 in fly brains were determined by qRT-PCR. n = 4, *p < 0.05, **p < 0.01 and ***p < 0.001 by Student’s t-test. (G) mRNA levels of genes related to oxidative stress responses in fly heads carrying a heterozygous mutation in Eaat1 were prominently elevated in wfs1 knockdown background compared to control background, as determined by qRT-PCR. n = 4, *p < 0.05, **p < 0.01 and ***p < 0.001 by Student’s t-test. (H-I) Riluzole increased the survival time in flies with neuronal and glial knockdown of wfs1 (H) and in flies carrying homozygous mutations of wfs1 with PiggyBac insertion (wfs1LL07290/LL07290) (I). The survival rates were determined by Kaplan-Meier survival analysis with log-rank test, and Holm-Sidak method was used for multiple comparison analysis (n = 138, mcherry RNAi with Riluzole 0 mM, n = 128, mcherry RNAi with Riluzole 5 mM, n = 102, wfs1 RNAi with Riluzole 0 mM, n = 101, wfs1 RNAi with Riluzole 5 mM, n = 82, wfs1LL07290/LL07290 with Riluzole 0 mM, n = 85, wfs1LL07290/LL07290 with Riluzole 5 mM). The statistical significance was indicated in the figure. Genotypes and ages of flies are described in S1 Table.
Next, we investigated whether wfs1 deficiency increases the susceptibility of flies to neuronal dysfunction caused by altered neuronal excitability. In Drosophila, loss of Eaat1 causes age-dependent locomotor defects [54,55]. We found that the heterozygous Eaat1 mutant alone did not cause locomotor defects up to 28 days of age (Fig 6E, left). By contrast, in the wfs1 knockdown background, the heterozygous Eaat1 mutation caused locomotor defects starting at 21 days (Fig 6E, right). These results suggest that wfs1 deficiency renders neurons vulnerable to neuronal dysfunction caused by altered neuronal excitability.
To investigate the mechanisms underlying the genetic interaction between Eaat1 and wfs1, we first examined whether the UPR was induced in flies with a combination of Eaat1 heterozygous mutations and neuronal knockdown of wfs1. Eaat1 heterozygous mutations significantly upregulated the mRNA expression of UPR marker genes in the wfs1 knockdown background, but not in the wild-type background in fly heads (Fig 6F). Since neuronal knockdown of wfs1 alone did not induce the expression of UPR marker genes (Fig 4A), these results suggest that knockdown of wfs1 renders brain cells (neurons and/or glial cells) vulnerable to ER stress associated with reduced Eaat1 function.
Oxidative stress is induced by impaired Eaat1 function in flies [54]. We therefore examined the effect of increased oxidative stress on the genetic interaction between Eaat1 and wfs1. qRT-PCR analysis showed that a heterozygous mutation of Eaat1 alone slightly upregulated the mRNA expression of three of eight oxidative stress-related genes in the wild-type background (Fig 6G, left), and this effect was enhanced in flies with neuronal knockdown of wfs1, in which five of eight genes were significantly upregulated at the mRNA level (Fig 6G, right). These results suggest that knockdown of wfs1 imposes oxidative stress to the cells under reduced Eaat1 function, which may contribute to the increased behavioral deficits in these flies.
We further examined whether correcting the imbalance of neural activity could suppress neuronal dysfunction in wfs1 knockdown flies. Since Eaat1 expression was decreased (Fig 6C and 6D) and the loss of one copy of Eaat1 worsened the behavioral deficits in wfs1 knockdown flies (Fig 6E), we treated flies with riluzole, which inhibits glutamate release and reduces extracellular glutamate levels, thereby suppressing excitotoxicity [54]. Although administration of riluzole did not suppress age-dependent locomotor defects (S8A Fig), it significantly increased the survival of wfs1 knockdown and mutant flies (Fig 6H and 6I). Interestingly, administration of riluzole also increased the lifespan of control flies (Fig 6H, mcherry RNAi), suggesting that riluzole treatment extends the lifespan of wfs1 knockdown flies by suppressing general age-related stresses. Such protective effects were not observed in flies treated with the anticholinergic agent orphenadrine (S8B and S8C Fig).
Taken together, these results suggest that behavioral deficits in wfs1 knockdown flies partly involve glutamatergic imbalance, and wfs1 deficiency increases the susceptibility to neuronal dysfunction caused by altered neuronal excitability in flies.
Neuronal knockdown of wfs1 increases susceptibility to axon degeneration caused by overexpression of human tau
Post-mortem studies show widespread axonal pathology in WS patients [56–58]. To determine whether wfs1 knockdown exacerbated axon degeneration, we used transgenic Drosophila expressing the Alzheimer’s disease-related human tau protein under the control of the pan-retinal GMR-GAL4 driver. Ectopic expression of human tau causes age-dependent and progressive degeneration in the lamina, the first synaptic neuropil of the optic lobe, which contains photoreceptor axons [59]. We found that wfs1 expression was induced by tau expression (Fig 7A) concomitant with a significant upregulation of the mRNA expression of oxidative stress-related genes (Fig 7B). These results suggest that wfs1 plays a protective role against tau-mediated neurodegeneration. Knockdown of wfs1 significantly increased axon degeneration caused by tau in the lamina at 3 and 7 days of age (Fig 7C, upper panels), whereas knockdown of wfs1 alone did not cause axon degeneration in the lamina at these ages (Fig 7C, lower panels). Knockdown of wfs1 did not alter tau total protein or phosphorylation levels (Fig 7D). We further examined whether overexpression of wfs1 could suppress tau-mediated neurodegeneration. Although there was a trend that wfs1 expression slightly suppressed retinal degeneration induced by tau, they did not reach statistical significance (S9 Fig).
(A) mRNA levels of wfs1 were induced by ectopic expression of human microtubule associated protein tau in fly eyes, as determined by qRT-PCR. n = 4, *p < 0.05 by Student’s t-test. (B) The mRNA levels of genes related to oxidative stress responses in flies expressing human tau were determined by qRT-PCR. n = 4, *p < 0.05, **p < 0.01 and ***p < 0.001 by Student’s t-test. (C) Neuronal knockdown of wfs1 exaggerated axon degeneration in the lamina caused by ectopic overexpression of human tau (upper panels). Neuronal knockdown of wfs1 alone did not cause axon degeneration in the lamina (lower panels). Representative images show the lamina in paraffin-embedded head section with hematoxylin and eosin (HE) staining from 3- and 7-day-old flies. Scale bars: 200 μm. Percentages of vacuole areas in the lamina (indicated by arrowheads in the images) are shown. n = 9–12 hemispheres, *p < 0.05 and ***p < 0.001 by Student’s t-test. (D) Neuronal knockdown of wfs1 did not alter either the total protein levels or phosphorylation levels of tau. Fly heads expressing tau alone (tau) or co-expressing tau and RNAi transgene for wfs1 (tau/wfs1 RNAi) were subjected to western blotting with anti-tau or anti-phospho tau antibodies. Nervana, a fly ortholog of ATPase Na+/K+ transporting subunit β 1, was used as the loading control. n = 3–4, no significant difference. (E) Overexpression of human tau in the lamina induced ER stress responses compared with control (left panel). Neuronal knockdown of wfs1 did not further increase ER stress responses caused by tau expression (right panel). The mRNA levels of Xbp1-RB, PEK and Hsc70-3 in fly heads were determined by qRT-PCR. n = 4, *p < 0.05, **p < 0.01 and ***p < 0.001 by Student’s t-test. Genotypes and ages of flies are described in S1 Table.
To explore the possible involvement of ER stress in the enhancement of neurodegeneration, we examined whether UPR gene expression was induced in flies with a combination of tau expression and wfs1 knockdown under the control of the GMR-GAL4 driver. Expression of tau alone in retinal cells slightly upregulated the mRNA expression of UPR marker genes (Fig 7E, left). However, the combination of tau expression and wfs1 knockdown did not further increase, but rather slightly decreased the expression levels of UPR marker genes (Fig 7E, right), suggesting that an increased UPR is not the primary mechanism underlying enhanced tau toxicity.
Taken together, these results suggest that wfs1 knockdown increases the vulnerability of neurons to axon degeneration induced by tau.
Discussion
Most WS patients die prematurely in association with severe neurological disabilities as a result of brain atrophy [1,24,25]; however, the mechanisms underlying neurodegeneration caused by WFS1 deficiency remain elusive. In this study, we investigated the effects of knockdown of wfs1, a fly homolog of WFS1, in the nervous system on neuronal integrity during aging. The results demonstrated that wfs1 expression was induced upon aging, and neuronal knockdown of wfs1 caused age-dependent behavioral deficits and neurodegeneration (Fig 1 and S1 Fig).
The process by which wfs1 deficiency induced behavioral deficits and neurodegeneration in our Drosophila model remained unclear. In pancreatic β cells, WFS1 deficiency causes chronic ER stress and subsequent cell death through the dysregulation of intracellular Ca2+ levels [14,15] and disruption of ER homeostasis [8,9,11,16]. In addition, a recent report using primary cultured neurons demonstrated that WFS1 deficiency alters Ca2+ homeostasis in the ER and promotes mitophagy, leading to alterations in mitochondrial distribution and dynamics [49]. We found that knockdown of wfs1 in the nervous system did not induce ER stress (Fig 4) or mitochondrial dysfunction (S6 Fig) even in aged fly brains. Moreover, autophagy flux was not significantly affected in these flies (S7 Fig). These results suggest that reductions in wfs1 function alone do not severely disrupt cellular functions, which directly causes neurodegeneration. Rather, wfs1 may play a protective role against various stressors associated with aging, and its deficiency increased the susceptibility to neurodegeneration in aged flies.
In support of this hypothesis, wfs1 expression was induced by aging and stressors (Figs 1, 5 and 7 and S5 Fig), and neuronal knockdown of wfs1 rendered neurons vulnerable to oxidative stress-, altered neuronal excitability- or Alzheimer’s associated tauopathy-induced behavioral deficits and neurodegeneration (Figs 5, 6 and 7). Moreover, although knockdown of wfs1 in neurons did not induce obvious stress responses (Figs 4 and 5C), wfs1 deficiency significantly augmented oxidative stress and ER stress responses under stressed conditions (Fig 6F and 6G). These results suggest that wfs1 deficiency modifies the onset, progression and severity of neurological and neurodegenerative phenotypes caused by a combination of complex environmental, genetic, and age-associated factors.
In this study, knockdown of wfs1 in neurons and glial cells significantly exaggerated behavioral deficits and premature death (Fig 2), suggesting that neuronal and glial wfs1 work in concert to maintain neuronal integrity in flies. The mRNA expression levels of Eaat1 and Grd, which are fly orthologs of glial glutamate transporters (SLC1A3) and GABA-A receptor α subunit (GABRA6), respectively, were significantly altered in these fly brains (Fig 6C). Moreover, loss of one copy of Eaat1 increased locomotor deficits induced by wfs1 deficiency (Fig 6E), whereas feeding of riluzole, which is thought to inhibit glutamate release as well as GABA uptake, significantly suppressed premature death phenotypes in these flies (Fig 6H and 6I). These results suggest that stresses caused by altered neuronal excitability, possibly due to an imbalance between glutamatergic and GABAergic tones, may underlie the observed behavioral deficits in flies with wfs1 deficiency.
Recent reports suggest that the neurological manifestations of WFS1 deficiency are associated with endocrine problems [3,20]. In addition to the ER, the WFS1 protein localizes to secretory granules and regulates intragranular acidification, proinsulin processing, and exocytosis in pancreatic β cells [40], in part by interacting with the V1A subunit of H+ V-ATPase [60]. Consistent with this, vasopressin processing is defective in some hypothalamic nuclei in the brain of WS patients [61], and the processing and secretion of growth and trophic factors is impaired in Wfs1-deficient mice [31]. We examined whether knockdown of wfs1 in neurons and glial cells alters the levels of a fly ortholog of Mesencephalic Astrocyte-derived Neurotrophic Factor (MANF) [62] in fly brains. Western blot analyses revealed that the level of MANF was not significantly altered in fly brains (S10 Fig). Further analysis is required to clarify the mechanism by which wfs1 functions in neurons and glial cells to maintain neuronal function and integrity in fly brains.
The wfs1 mutant and RNAi lines used in this study did not completely abolish wfs1 expression and function in flies. This indicates that some of the phenotypes induced by knockdown of wfs1 may be different from those caused by complete null mutation of wfs1. Nevertheless, this study demonstrated that wfs1 deficiency in the nervous system is sufficient to render neurons vulnerable to age-associated neurodegeneration in Drosophila. Our results also highlight the importance of the functions of wfs1 in both neuronal and glial cells. Moreover, our data revealed a novel genetic interaction between wfs1 and Eaat1, and suggest that altered neural activity and vulnerability to oxidative stress underlie neurological phenotypes in wfs1 deficient flies.
In conclusion, this study provides insight into the molecular mechanisms underlying neurodegeneration in WS and furthers our understanding of potential disease-modifying factors that determine susceptibility and resilience to age-associated neurodegenerative diseases such as Alzheimer’s disease.
Materials and methods
Drosophila genetics
Flies were maintained in standard cornmeal media at 25°C. Transgenic fly lines carrying UAS-Luciferase RNAi, UAS-human tau and UAS-Aβ42 were previously described [43,63]. Eaat1SM2 and a precise excision line Eaat1PE (used as a control line for Eaat1SM2) are kind gifts from Dr. D. J. van Meyel (McGill University) [55]. The elav-GAL4 (#458), Repo-GAL4 (#7415), GMR-GAL4 (#1104), UAS-wfs1 RNAiTRiP (#53330), UAS-mcherry RNAi (#35785), wfs1e03461 (#18157), wfs1MI14041 (#59250), UAS-wfs1 (#8356), UAS-wfs1 (#8357), UAS-mitoGFP (#8442) and UAS-Luciferase (#35788), Opa1S3475 (#12188) were obtained from the Bloomington Stock Center. UAS-wfs1 RNAiGD (#42664) was obtained from the Vienna Drosophila RNAi Center. wfs1LL07290 (#142011) was obtained from Kyoto Stock Center. Genotypes and ages of all flies used in this study are provided in S1 Table. Experiments were performed using age-matched male or female flies.
Climbing assay
The forced climbing assay was performed as previously described [63,64]. Approximately 25 male flies were placed in an empty plastic vial. The vial was then gently tapped to knock all of the flies to the bottom. The numbers of flies in the top, middle, or bottom thirds of the vial were scored after 10 seconds. The percentages of flies that stayed at the bottom were subjected to statistical analyses.
Histological analysis
Preparation of paraffin sections, hematoxylin and eosin staining, and analysis of neurodegeneration were performed as described previously [59]. Heads of male or female flies were fixed in 4% paraformaldehyde for 24 h at 4°C and embedded in paraffin. Serial sections (6μm thickness) through the entire heads were prepared, stained with hematoxylin and eosin (Sigma-Aldrich), and examined by bright-field microscopy. Images of the sections were captured with AxioCam 105 color (Carl Zeiss). For quantification, we focused on analyzing sections covering the optic lobe, central neuropil, or lamina regions. We selected a section with the most severe neurodegeneration in each individual fly and the area of vacuoles was measured using Image J (NIH). Images of the external eye structures were captured with OLYMPUS DP26 CCD Camera (OLYMPUS), and the external eye areas were measured by ImageJ.
Lifespan analysis
Lifespan analysis was performed as described previously [63,64]. Food vials containing 25 male flies were placed on their sides at 25°C under conditions of 70% humidity and a 12:12-h light:dark cycle. Food vials were changed every 3–4 days, and the number of dead flies was counted each time. At least four vials for each genotype were prepared.
Hydrogen peroxide exposure assays
Flies were starved with 2% agar medium for 2 hrs before hydrogen peroxide (H2O2) treatment. Round filter paper was placed on the bottom of empty vial and 120 μl of 5% H2O2 (Wako Pure Chemical) in 10% sucrose (Nacalai Tesque) solution was added to the filter paper. The dead flies were scored every 24 hrs. At least 85 male flies (11-day-old) per genotype were used to perform this experiment. For control experiment, 25–30 male flies (15-day-old) per genotype were administrated with 120 μl of 10% sucrose solution.
Righting reflex assay
We slightly modified the protocol described in the previous study [53]. A single male fly was placed in a 1.5 ml micro test tube and was subjected to a brief mechanical shock by vortexing for 5 seconds. The fly was tapped into a supine position and the time required to right itself was measured. At least ten flies were used to calculate the mean value and statistical significance was determined as described below.
Drug feeding
Flies were fed with the food containing 0.2, 1, or 5 mM riluzole (Tokyo Chemical Industry), 10, 100, or 1000 μM orphenadrine (Tokyo Chemical Industry) or vehicle (final concentration 1% ethanol for riluzole or final concentration 1% water for orphenadrine) from the day after eclosion. These food vials were changed every 3–4 days.
Western blotting
Western blotting was performed as described previously [59]. Ten fly heads for each genotype were homogenized in Tris-Glycine SDS sample buffer, and the same amount of the lysate was loaded to each lane of 10%, 12.5% or 15% Tris-Glycine gels and transferred to nitrocellulose membrane. The membranes were blocked with 5% nonfat dry milk, blotted with the antibodies described below, incubated with appropriate secondary antibody and developed using ECL Prime Western Blotting Detection Reagent (GE Healthcare Life Sciences). The membranes were also probed with anti-tubulin, and used as the loading control for other blots in each experiment. Anti-tubulin (Sigma-Aldrich), anti-tau (Merck Millipore), anti-non phospho tau (Merck Millipore), anti-pSer202 tau (Thermo Fisher Scientific), anti-pThr231 tau (Thermo Fisher Scientific), anti-pSer404 tau (Abcam), anti-pSer422 tau (Abcam), anti-Nervana (Developmental Studies Hybridoma Bank), anti-VDAC1 (Abcam), anti-NDUFS3 (Abcam), anti-MnSOD (Enzo Life Sciences), anti-Atg8 (Merck Millipore) and anti-ref(2)P (Abcam) antibodies were purchased. Anti-MANF is a kind gift from Dr. T. I. Heino (University of Helsinki). Imaging was performed with ImageQuant LAS 4000 (GE Healthcare Life Sciences), and the signal intensity was quantified using Image J (NIH).
RNA extraction and quantitative real time PCR analysis
Quantitative real time PCR analysis was performed as described previously [59]. More than 25 flies for each genotype were collected and frozen. Heads were mechanically isolated, and total RNA was extracted using TRIzol Reagent (Thermo Fisher Scientific) according to the manufacturer’s protocol with an additional centrifugation step (16,000 × g for 10 min) to remove cuticle membranes prior to the addition of chloroform. Total RNA was reverse-transcribed using PrimeScript RT-PCR kit (TaKaRa Bio), and the resulting cDNA was used as a template for PCR on a CFX96 real time PCR detection system (Bio-Rad Laboratories). The average threshold cycle value was calculated from at least three replicates per sample. Expression of genes of interest was standardized relative to GAPDH1. Primer sequences used in this study were described below;
wfs1 (Drosophila) 167 bp (for the Bloomington line 53330)
Forward; 5’-CCGAGACGAATACTCTGCCC-3’
Reverse; 5’-ATTGGACACCCGCGAGATTT-3’
wfs1 (Drosophila) 189 bp (for the VDRC line 42664)
Forward; 5’-CTTCTGGTGCCTGTCTTCGT-3’
Reverse; 5’-CAACAAGCACGCTGTTGTGA-3’
Xbp1-RB (Drosophila) 238 bp
Forward; 5’-CAACCTTGGATCTGCCGCAGGG-3’
Reverse; 5’-CGCTCCAGCGCCTGTTTCCAG-3’
PEK (Drosophila) 241 bp
Forward; 5’-CTGCGCAGTCTTCGGGACGG-3’
Reverse; 5’-AGCTGCTGAAGGTGCGGCTG-3’
Hsc70-3 (Drosophila) 95 bp
Forward; 5’-TCCCGATGCCGATCCCGAGG-3’
Reverse; 5’-CGCCAGCACCCTGGTACAGC-3’
Sod1 (Drosophila) 160 bp
Forward; 5’-GTTCGGTGACAACACCAATG-3’
Reverse; 5’-GGAGTCGGTGATGTTGACCT-3’
Sod2 (Drosophila) 189 bp
Forward; 5’-GCTTCAACAAGAAGTCGGGC-3’
Reverse; 5’-AGATGTCATCCCAGTTGGCG-3’
Cat (Drosophila) 287 bp
Forward; 5’-TACGAGCAGGCCAAGAAGTT-3’
Reverse; 5’-ACCTTGTACGGGCAGTTCAC-3’
PHGPx (Drosophila) 105 bp
Forward; 5’-ACCTAAAGGCCAAGCAGACC-3’
Reverse; 5’-TCGGGGCATATCGGTTGATG-3’
Trx2 (Drosophila) 282 bp
Forward; 5’-ATCTCGATGGACAGCTGACC-3’
Reverse; 5’-CCTTGATGACATCCTCCAGAC-3’
GstD1 (Drosophila) 117 bp
Forward; 5’-TGGGAACGCTGTACCAGAG-3’
Reverse; 5’-AGGTGTTCAGGAACTCGAAGG-3’
GstD2 (Drosophila) 66 bp
Forward; 5’-GCCGCACGGTCATCATG-3’
Reverse; 5’-TGGTGTTCAGTAGCTTCTTGTTCAG-3’
GSS (Drosophila) 223 bp
Forward; 5’-TGGGACCAGCAAGTAAAACC-3’
Reverse; 5’-TCGCGAATGTAGAACTCGTG-3’
Eaat1 (Drosophila) 188 bp
Forward; 5’-TGCTCTGTTCATCGCCCAAT-3’
Reverse; 5’-CGACGGCTATGATGAGGGAC-3’
VGlut (Drosophila) 164 bp
Forward; 5’-TTCATCGCCTCCAAGTTCCC-3’
Reverse; 5’-GCTGGATAGGTAACGCCCTC-3’
Atpα (Drosophila) 190 bp
Forward; 5’-ACATGGTGCCAGCCATTTCA-3’
Reverse; 5’-AAGCCGTTCTCAGCCATGAT-3’
Lcch3 (Drosophila) 183 bp
Forward; 5’-CCGAGACGTGTTCAACGACA-3’
Reverse; 5’-GGCTATGTCCGGTGCCATAA-3’
Grd (Drosophila) 194 bp
Forward; 5’-TTTGGCTACACAACGTCGGA-3’
Reverse; 5’-GGTCGTGGTGGATCCTTGTT-3’
CG8916 (Drosophila) 182 bp
Forward; 5’-TTGAGTCCAAGAGCGGTGTC-3’
Reverse; 5’-CGTTTGGGTGGTTCTCTCCA-3’
Rdl (Drosophila) 186 bp
Forward; 5’-TGGCTCAATCGCAATGCAAC-3’
Reverse; 5’-GACCGTGGCGTATTCCAGTA-3’
CG12344 (Drosophila) 178 bp
Forward; 5’-CGAGAGCTTCTCGTCGAACA-3’
Reverse; 5’-GAAGTATACGGTGAGGCGGG-3’
GABA-B-R1 (Drosophila) 173 bp
Forward; 5’-CTCAGGGCGATCGTATTGCT-3’
Reverse; 5’-GGTGCGTAGAACATGGGTGA-3’
GABA-B-R2 (Drosophila) 178 bp
Forward; 5’-TGGCGGGTGCATTCGATATT-3’
Reverse; 5’-TCTCGTGATGCAAGGGTTCC-3’
GABA-B-R3 (Drosophila) 181 bp
Forward; 5’-AATTCGCACAGCAATCTGCC-3’
Reverse; 5’-ACAGCTCAAAGAGTCCGAGC-3’
sima (Drosophila) 213 bp
Forward; 5’-AGCCCAATCTGCCGCCAACC-3’
Reverse; 5’-TGGAGGCCAGGTGGTGGGAC-3’
Srl (Drosophila) 136 bp
Forward; 5’-GGATTCACGAATGCTAAATGTGTTCC-3’
Reverse; 5’-GATGGGTAGGATGCCGCTCAG-3’
Nup133 (Drosophila) 180 bp
Forward; 5’-GGGCCATGACGTACTGGAAA-3’
Reverse; 5’-ATCTTGTGCCGCATGTCGTA-3’
Marf (Drosophila) 199 bp
Forward; 5’-CGCTATCCCGGTTCAACTCA-3’
Reverse; 5’-TGCAGGGCGTTGATAAAGGT-3’
Opa1 (Drosophila) 196 bp
Forward; 5’-GCTACGATACGGGCTACACC-3’
Reverse; 5’-CGGAACTGAGCCACATGGTA-3’
Fis1 (Drosophila) 184 bp
Forward; 5’-CATCCAGATGGAAGGCGTGA-3’
Reverse; 5’-CCACCATACCCTTTGCCACT-3’
Drp1 (Drosophila) 166 bp
Forward; 5’-TACTGCTGCACAATCGAGGG-3’
Reverse; 5’-CATTCCGGATGGCTGTCAGT-3’
tau (Human) 184 bp
Forward; 5’-ATGCACCAAGACCAAGAGGG-3’
Reverse; 5’-TCGTTTTACCATCAGCCCCC-3’
GAPDH1 (Drosophila) 109 bp
Forward; 5’-GACGAAATCAAGGCTAAGGTCG-3’
Reverse; 5’-AATGGGTGTCGCTGAAGAAGTC-3’
Construction of Drosophila wfs1 expression vector
cDNA encoding the full length of Drosophila wfs1 (isoform C) were cloned by PCR from Drosophila genome from UAS-wfs1 fly, and HA tag was fused at the C-terminus. The cDNA was subcloned into a pUAST vector.
Cell culture and immunostaining
Drosophila S2 cells were maintained in Schneider's Drosophila media (Thermo Fisher Scientific) supplemented with 10% FBS in a 25°C incubator. S2 cells were transfected with actin-GAL4 and UAS-wfs1-HA plasmids using HilyMax (Dojindo) following the manufacturer’s protocol. Cells were fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS) at 48 h after transfection and stained with anti-HA (Santa Cruz Biotechnology) or anti-KDEL (Enzo Life Sciences) antibody. Antibodies were detected by anti-rabbit IgG conjugated Alexa 488 (Abcam) or ant-mouse IgG conjugated Alexa 647 (Abcam). ER and mitochondria were labeled by Concanavalin A (ConA) conjugated Alexa 647 (Thermo Fisher Scientific) and Mitotracker (Thermo Fisher Scientific) respectively. The stained cells were analyzed using a confocal microscope (Carl Zeiss, LSM 780).
ATP assay
ATP contents in fly brains were analyzed using ATP Bioluminescence Assay Kit CLSII (Roche) according to the manufacturer’s protocol. Briefly, dissected fly brains were homogenized in Tris-EDTA buffer and boil at 100°C for 2 min to inactivate ATPase. Samples were centrifuged at 16,000 × g for 5 min and the supernatant was used for ATP assay. ATP levels were calculated by standard curves and normalized by protein levels.
Confocal analysis for mitochondrial distribution
Mitochondrial distribution in fly neuron was analyzed as described previously [65]. Fly brains were dissected in cold PBS, fixed in PBS containing 4% paraformaldehyde, and then placed under vacuum in PBS containing 4% paraformaldehyde and 0.25% Triton X-100. The fluorescence intensity in the mushroom body regions was analyzed using a confocal microscope (Carl Zeiss, LSM 780) and quantified using Image J (NIH).
Statistics
All results were expressed as mean ± s.d. (for climbing assay) or mean ± s.e.m. Unpaired Student’s t-test (Excel, Microsoft) was used to determine statistical significance as indicated in the figure legends. Mann-Whitney U-test was used to determine statistical significance for righting reflex assay. Kaplan-Meier survival analyses with log-rank tests (SigmaPlot 11.0, Systat Software Inc.) were used to determine statistical significance for lifespan analysis. One-way ANOVA followed by Tukey's post hoc test was used to determine statistical significance as indicated in the figure legends. * indicates p < 0.05, ** indicates p < 0.01 and *** indicates p < 0.001 throughout the manuscript.
Supporting information
S1 Table. Genotype and age of flies used in this study.
https://doi.org/10.1371/journal.pgen.1007196.s001
(DOCX)
S1 Fig. Knockdown of wfs1, a fly homolog of WFS1, in the nervous system causes behavioral deficits and shortens lifespan of flies.
(A) mRNA expression levels of wfs1 in heads of flies carrying the RNAi transgene (GD line; wfs1 RNAiGD) targeting wfs1 were analyzed by qRT-PCR. n = 4, ***p < 0.001 by Student’s t-test. (B) Knockdown of wfs1 in neurons induced age-dependent locomotor deficits as revealed by climbing assay. Average percentages of flies that climbed to the top (white), climbed to the middle (light gray), or stayed at the bottom (dark gray) of the vials. Percentages of flies that stayed at the bottom were subjected to statistical analyses. The experiments were repeated two times and representative data is shown. n = 5, *p < 0.05 and ***p < 0.001 by Student’s t-test. (C) Knockdown of wfs1 in both neurons and glial cells (elav-Repo) significantly shortened lifespan of flies (n = 132, wfs1 RNAi group or 233, Luciferase RNAi group). The lifespans of flies were determined by Kaplan-Meier survival analysis with log-rank test and statistical significance was indicated in the figure. Genotypes and ages of flies are described in S1 Table.
https://doi.org/10.1371/journal.pgen.1007196.s002
(TIF)
S2 Fig. Mutations in wfs1 gene cause behavioral deficits and shorten lifespan of flies.
(A-B) The mRNA expression levels of wfs1 and Nup133 in wfs1 mutant PiggyBac lines, wfs1e03461/e03461 (A) and wfs1LL07290/LL07290 (B) were analyzed by qRT-PCR. n = 4, **p < 0.01 and ***p < 0.001 by Student’s t-test. (C) The flies carrying a heterozygous mutation (wfs1LL07290/+) and homozygous mutation (wfs1LL07290/LL07290) of wfs1 induced age-dependent locomotor deficits as revealed by climbing assay. Average percentages of flies that climbed to the top (white), climbed to the middle (light gray), or stayed at the bottom (dark gray) of the vials. Percentages of flies that stayed at the bottom were subjected to statistical analyses. n = 5 independent experiments, *p < 0.05, **p < 0.01 and ***p < 0.001 by Student’s t-test. (D) A heterozygous mutation (wfs1LL07290/+) and homozygous mutation (wfs1LL07290/LL07290) of wfs1 shortened the lifespan of flies. The lifespans of flies were determined by Kaplan-Meier survival analysis with log-rank test, and Holm-Sidak method was used for multiple comparison analysis (n = 316, Control, n = 314, wfs1LL07290/+, n = 92, wfs1LL07290/LL07290). The statistical significance was indicated in the figure. Genotypes and ages of flies are described in S1 Table.
https://doi.org/10.1371/journal.pgen.1007196.s003
(TIF)
S3 Fig. Predicted amino acid sequence of wfs1 in the flies carrying homozygous MiMIC insertions in the wfs1 gene.
Alignment of amino acid sequences predicted from the DNA sequence of wfs1 with the MiMIC insertion (wfs1_MI140411) and that of wild-type wfs1 from NCBI database (wfs1_NP_001189267.1).
https://doi.org/10.1371/journal.pgen.1007196.s004
(TIF)
S4 Fig. Drosophila wfs1 co-localizes with ER and mitochondria markers in Drosophila S2 cells.
(A-C) Localization of wfs1-HA in Drosophila Schneider 2 (S2) cells. S2 cells were transiently transfected with wfs1-HA and double stained with anti-HA tag antibody (for wfs1-HA) and anti-KDEL (ER marker) antibody (A), Concanavalin A (ConA) conjugated Alexa Fluor (ER marker) (B) or Mitotracker (mitochondrial marker) (C). Nuclei were counterstained with DAPI. Samples were analyzed by confocal microscopy. Scale bars: 5 μm.
https://doi.org/10.1371/journal.pgen.1007196.s005
(TIF)
S5 Fig. ER stress induces wfs1 expression in Drosophila.
(A) Neuronal expression of misfolding prone amyloid-β42 peptides (Aβ42) in the ER increases mRNA expression levels of Xbp1-RB, PEK and Hsc70-3 in fly heads, as determined by qRT-PCR. n = 4, **p < 0.01 and ***p < 0.001 by Student’s t-test. (B) mRNA levels of wfs1 were increased in fly heads expressing Aβ42, as determined by qRT-PCR. n = 4, **p < 0.01 by Student’s t-test. Genotypes and ages of flies are described in S1 Table.
https://doi.org/10.1371/journal.pgen.1007196.s006
(TIF)
S6 Fig. Neuronal knockdown of wfs1 does not induce mitochondrial dysfunctions.
(A) Double knockdown of wfs1 in both neurons and glial cells did not affect the level of total ATP content. Adult fly brains expressing RNAi transgene for wfs1 in neurons and glial cells were subjected to the experiment. n = 3 independent experiments, no significant difference. (B) mRNA levels of genes related to mitochondrial fission and fusion were not altered in fly brains with neuronal and glial knockdown of wfs1, as determined by qRT-PCR. n = 4, *p < 0.05 by Student’s t-test. (C) Fly heads expressing RNAi transgene for wfs1 were subjected to western blotting with anti-VDAC1, anti-NDUFS3 and anti-MnSOD antibodies. Tubulin was used as the loading control. n = 4, no significant difference. (D) A schematic diagram of mitochondria-targeted GFP (mito-GFP) and mito-GFP signals in the mushroom body structure in the fly brain. A GFP is fused to a mitochondria-targeting signal of human cytochrome c oxidase subunit VIII (cCoxVIII) (left panel). Fly brains expressing mito-GFP in neurons were dissected and confocal images were captured. Lobe tips (Axons), Kenyon cells (Cell bodies) and Calyx (Dendrites) are indicated (right panel). (E) Neuronal knockdown of wfs1 did not disrupt mitochondrial distribution in fly neurons. Representative images show the mito-GFP distribution in the mushroom structure in the fly brain at 7-, 21-, and 42-day-old. Signal intensities of mito-GFP in the axons, dendrites and cell bodies of the mushroom body structure in control or wfs1 RNAi fly brains were quantified. n = 8–10 hemispheres, ***p < 0.001 by Student’s t-test. (F) A heterozygous Opa1 mutation (Opa1s3475) did not exacerbated age-dependent locomotor deficits caused by neuronal knockdown of wfs1. Average percentages of flies that climbed to the top (white), climbed to the middle (light gray), or stayed at the bottom (dark gray) of the vials. Percentages of flies that stayed at the bottom were subjected to statistical analyses. n = 3–5 independent experiments, no significant difference. Genotypes and ages of flies are described in S1 Table.
https://doi.org/10.1371/journal.pgen.1007196.s007
(TIF)
S7 Fig. Neuronal knockdown of wfs1 does not induce lysosome/autophagy defects in the fly brains.
Fly heads expressing RNAi transgene for wfs1 or mcherry in neurons were subjected to western blotting with anti-Atg8 and anti-ref(2)P antibodies. Tubulin was used as a loading control. The ratios of Atg8-II/Atg8-I were analyzed. Atg8; n = 12, ref(2)P; n = 4, no significant difference. Genotypes and ages of flies are described in S1 Table.
https://doi.org/10.1371/journal.pgen.1007196.s008
(TIF)
S8 Fig. Neither glutamate release inhibitor riluzole nor anticholinergic agent orphenadrine alter the age-dependent locomotor deficits caused by neuronal knockdown of wfs1.
(A-B) Glutamate release inhibitor riluzole (A) and anticholinergic agent orphenadrine (B) did not alter age-dependent locomotor deficits in both wfs1 knockdown background (left panels) and control background (right panels). Average percentages of flies that climbed to the top (white), climbed to the middle (light gray), or stayed at the bottom (dark gray) of the vials. Percentages of flies that stayed at the bottom were subjected to statistical analyses. n = 3 independent experiments, no significant difference. (C) Anticholinergic agent orphenadrine did not alter the lifespan of flies with neuronal and glial knockdown of wfs1. The lifespans of flies were determined by Kaplan-Meier survival analysis with log-rank test and Holm-Sidak method was used for multiple comparison analysis (n = 109, mcherry RNAi with Orphenadrine 0 mM, n = 107, mcherry RNAi with Orphenadrine 1 mM, n = 103, wfs1 RNAi with Orphenadrine 0 mM, n = 102, wfs1 RNAi with Orphenadrine 1 mM). The statistical significance was indicated in the figure. Genotypes and ages of flies are described in S1 Table.
https://doi.org/10.1371/journal.pgen.1007196.s009
(TIF)
S9 Fig. Overexpression of wfs1 does not suppress the axon degeneration caused by human tau.
(A) mRNA levels of tau were determined by qRT-PCR. n = 4, no significant difference by one-way ANOVA with Tukey’s post hoc test. (B) Overexpression of wfs1 did not suppressed retinal degeneration induced by ectopic overexpression of human tau. Scale bar, 200 μm. (C) Overexpression of wfs1 did not suppress axon degeneration in the lamina caused by ectopic overexpression of human tau. Representative images show the lamina in paraffin-embedded head section with hematoxylin and eosin (HE) staining from 7-day-old flies. Scale bars: 200 μm. Percentages of vacuole areas in the lamina (indicated by arrowheads in the images) are shown. n = 12 hemispheres, no significant difference by one-way ANOVA with Tukey’s post hoc test. Genotypes and ages of flies are described in S1 Table.
https://doi.org/10.1371/journal.pgen.1007196.s010
(TIF)
S10 Fig. Neuronal and glial knockdown of wfs1 does not alter the levels of neurotrophic factor, MANF, in fly brains.
Fly heads expressing RNAi transgene for wfs1 or mcherry in both neurons and glial cells were subjected to western blotting with anti-MANF antibody. Tubulin was used as the loading control. n = 4, no significant difference. Genotypes and ages of flies are described in S1 Table.
https://doi.org/10.1371/journal.pgen.1007196.s011
(TIF)
Acknowledgments
We thank Drs. T. I. Heino and D. J. van Meyel; TRiP at Harvard Medical School (NIH/NIGMS R01-GM084947); the Bloomington stock center; and the Vienna Drosophila RNAi center for fly stocks, cDNA and antibodies. We thank S. Chikamatsu, M. Satoh and Y. Ojio for technical assistance.
References
- 1. Barrett TG, Bundey SE, Macleod AF (1995) Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet 346: 1458–1463. pmid:7490992
- 2. de Heredia ML, Cleries R, Nunes V (2013) Genotypic classification of patients with Wolfram syndrome: insights into the natural history of the disease and correlation with phenotype. Genet Med 15: 497–506. pmid:23429432
- 3. Marshall BA, Permutt MA, Paciorkowski AR, Hoekel J, Karzon R, et al. (2013) Phenotypic characteristics of early Wolfram syndrome. Orphanet J Rare Dis 8: 64. pmid:23981289
- 4. Khanim F, Kirk J, Latif F, Barrett TG (2001) WFS1/wolframin mutations, Wolfram syndrome, and associated diseases. Hum Mutat 17: 357–367. pmid:11317350
- 5. Rigoli L, Lombardo F, Di Bella C (2011) Wolfram syndrome and WFS1 gene. Clin Genet 79: 103–117. pmid:20738327
- 6. Inoue H, Tanizawa Y, Wasson J, Behn P, Kalidas K, et al. (1998) A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat Genet 20: 143–148. pmid:9771706
- 7. Strom TM, Hortnagel K, Hofmann S, Gekeler F, Scharfe C, et al. (1998) Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. Hum Mol Genet 7: 2021–2028. pmid:9817917
- 8. Fonseca SG, Fukuma M, Lipson KL, Nguyen LX, Allen JR, et al. (2005) WFS1 is a novel component of the unfolded protein response and maintains homeostasis of the endoplasmic reticulum in pancreatic beta-cells. J Biol Chem 280: 39609–39615. pmid:16195229
- 9. Fonseca SG, Ishigaki S, Oslowski CM, Lu S, Lipson KL, et al. (2010) Wolfram syndrome 1 gene negatively regulates ER stress signaling in rodent and human cells. J Clin Invest 120: 744–755. pmid:20160352
- 10. Shang L, Hua H, Foo K, Martinez H, Watanabe K, et al. (2014) beta-cell dysfunction due to increased ER stress in a stem cell model of Wolfram syndrome. Diabetes 63: 923–933. pmid:24227685
- 11. Yamada T, Ishihara H, Tamura A, Takahashi R, Yamaguchi S, et al. (2006) WFS1-deficiency increases endoplasmic reticulum stress, impairs cell cycle progression and triggers the apoptotic pathway specifically in pancreatic beta-cells. Hum Mol Genet 15: 1600–1609. pmid:16571599
- 12. Zatyka M, Da Silva Xavier G, Bellomo EA, Leadbeater W, Astuti D, et al. (2015) Sarco(endo)plasmic reticulum ATPase is a molecular partner of Wolfram syndrome 1 protein, which negatively regulates its expression. Hum Mol Genet 24: 814–827. pmid:25274773
- 13. Lu S, Kanekura K, Hara T, Mahadevan J, Spears LD, et al. (2014) A calcium-dependent protease as a potential therapeutic target for Wolfram syndrome. Proc Natl Acad Sci U S A 111: E5292–5301. pmid:25422446
- 14. Osman AA, Saito M, Makepeace C, Permutt MA, Schlesinger P, et al. (2003) Wolframin expression induces novel ion channel activity in endoplasmic reticulum membranes and increases intracellular calcium. J Biol Chem 278: 52755–52762. pmid:14527944
- 15. Takei D, Ishihara H, Yamaguchi S, Yamada T, Tamura A, et al. (2006) WFS1 protein modulates the free Ca(2+) concentration in the endoplasmic reticulum. FEBS Lett 580: 5635–5640. pmid:16989814
- 16. Ishihara H, Takeda S, Tamura A, Takahashi R, Yamaguchi S, et al. (2004) Disruption of the WFS1 gene in mice causes progressive beta-cell loss and impaired stimulus-secretion coupling in insulin secretion. Hum Mol Genet 13: 1159–1170. pmid:15056606
- 17. Riggs AC, Bernal-Mizrachi E, Ohsugi M, Wasson J, Fatrai S, et al. (2005) Mice conditionally lacking the Wolfram gene in pancreatic islet beta cells exhibit diabetes as a result of enhanced endoplasmic reticulum stress and apoptosis. Diabetologia 48: 2313–2321. pmid:16215705
- 18. Sandhu MS, Weedon MN, Fawcett KA, Wasson J, Debenham SL, et al. (2007) Common variants in WFS1 confer risk of type 2 diabetes. Nat Genet 39: 951–953. pmid:17603484
- 19. Chaussenot A, Bannwarth S, Rouzier C, Vialettes B, Mkadem SA, et al. (2011) Neurologic features and genotype-phenotype correlation in Wolfram syndrome. Ann Neurol 69: 501–508. pmid:21446023
- 20. Rohayem J, Ehlers C, Wiedemann B, Holl R, Oexle K, et al. (2011) Diabetes and neurodegeneration in Wolfram syndrome: a multicenter study of phenotype and genotype. Diabetes Care 34: 1503–1510. pmid:21602428
- 21. Galluzzi P, Filosomi G, Vallone IM, Bardelli AM, Venturi C (1999) MRI of Wolfram syndrome (DIDMOAD). Neuroradiology 41: 729–731. pmid:10552021
- 22. Rando TA, Horton JC, Layzer RB (1992) Wolfram syndrome: evidence of a diffuse neurodegenerative disease by magnetic resonance imaging. Neurology 42: 1220–1224. pmid:1603350
- 23. Scolding NJ, Kellar-Wood HF, Shaw C, Shneerson JM, Antoun N (1996) Wolfram syndrome: hereditary diabetes mellitus with brainstem and optic atrophy. Ann Neurol 39: 352–360. pmid:8602754
- 24. Barrett TG, Bundey SE (1997) Wolfram (DIDMOAD) syndrome. J Med Genet 34: 838–841. pmid:9350817
- 25. Urano F (2016) Wolfram Syndrome: Diagnosis, Management, and Treatment. Curr Diab Rep 16: 6. pmid:26742931
- 26. Swift M, Swift RG (2000) Psychiatric disorders and mutations at the Wolfram syndrome locus. Biol Psychiatry 47: 787–793. pmid:10812037
- 27. Swift M, Swift RG (2005) Wolframin mutations and hospitalization for psychiatric illness. Mol Psychiatry 10: 799–803. pmid:15852062
- 28. Swift RG, Polymeropoulos MH, Torres R, Swift M (1998) Predisposition of Wolfram syndrome heterozygotes to psychiatric illness. Mol Psychiatry 3: 86–91. pmid:9491819
- 29. Kato T, Ishiwata M, Yamada K, Kasahara T, Kakiuchi C, et al. (2008) Behavioral and gene expression analyses of Wfs1 knockout mice as a possible animal model of mood disorder. Neurosci Res 61: 143–158. pmid:18343518
- 30. Luuk H, Plaas M, Raud S, Innos J, Sutt S, et al. (2009) Wfs1-deficient mice display impaired behavioural adaptation in stressful environment. Behav Brain Res 198: 334–345. pmid:19041897
- 31. Shrestha P, Mousa A, Heintz N (2015) Layer 2/3 pyramidal cells in the medial prefrontal cortex moderate stress induced depressive behaviors. Elife 4.
- 32. Bonnet Wersinger D, Benkafadar N, Jagodzinska J, Hamel C, Tanizawa Y, et al. (2014) Impairment of visual function and retinal ER stress activation in Wfs1-deficient mice. PLoS One 9: e97222. pmid:24823368
- 33. Plaas M, Seppa K, Reimets R, Jagomae T, Toots M, et al. (2017) Wfs1- deficient rats develop primary symptoms of Wolfram syndrome: insulin-dependent diabetes, optic nerve atrophy and medullary degeneration. Sci Rep 7: 10220. pmid:28860598
- 34. Pereira AC, Gray JD, Kogan JF, Davidson RL, Rubin TG, et al. (2016) Age and Alzheimer's disease gene expression profiles reversed by the glutamate modulator riluzole. Mol Psychiatry.
- 35. Kretzschmar D, Hasan G, Sharma S, Heisenberg M, Benzer S (1997) The swiss cheese mutant causes glial hyperwrapping and brain degeneration in Drosophila. J Neurosci 17: 7425–7432. pmid:9295388
- 36. Kawano J, Tanizawa Y, Shinoda K (2008) Wolfram syndrome 1 (Wfs1) gene expression in the normal mouse visual system. J Comp Neurol 510: 1–23. pmid:18613120
- 37. Yamamoto H, Hofmann S, Hamasaki DI, Kreczmanski P, Schmitz C, et al. (2006) Wolfram syndrome 1 (WFS1) protein expression in retinal ganglion cells and optic nerve glia of the cynomolgus monkey. Exp Eye Res 83: 1303–1306. pmid:16928372
- 38. Celniker SE, Dillon LA, Gerstein MB, Gunsalus KC, Henikoff S, et al. (2009) Unlocking the secrets of the genome. Nature 459: 927–930. pmid:19536255
- 39. Takeda K, Inoue H, Tanizawa Y, Matsuzaki Y, Oba J, et al. (2001) WFS1 (Wolfram syndrome 1) gene product: predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain. Hum Mol Genet 10: 477–484. pmid:11181571
- 40. Hatanaka M, Tanabe K, Yanai A, Ohta Y, Kondo M, et al. (2011) Wolfram syndrome 1 gene (WFS1) product localizes to secretory granules and determines granule acidification in pancreatic beta-cells. Hum Mol Genet 20: 1274–1284. pmid:21199859
- 41. Philbrook C, Fritz E, Weiher H (2005) Expressional and functional studies of Wolframin, the gene function deficient in Wolfram syndrome, in mice and patient cells. Exp Gerontol 40: 671–678. pmid:16087305
- 42. Mori K (2009) Signalling pathways in the unfolded protein response: development from yeast to mammals. J Biochem 146: 743–750. pmid:19861400
- 43. Sekiya M, Maruko-Otake A, Hearn S, Sakakibara Y, Fujisaki N, et al. (2017) EDEM Function in ERAD Protects against Chronic ER Proteinopathy and Age-Related Physiological Decline in Drosophila. Dev Cell 41: 652–664 e655. pmid:28633019
- 44. Vafai SB, Mootha VK (2012) Mitochondrial disorders as windows into an ancient organelle. Nature 491: 374–383. pmid:23151580
- 45. Barrett TG, Scott-Brown M, Seller A, Bednarz A, Poulton K, et al. (2000) The mitochondrial genome in Wolfram syndrome. J Med Genet 37: 463–466. pmid:10928858
- 46. Bu X, Rotter JI (1993) Wolfram syndrome: a mitochondrial-mediated disorder? Lancet 342: 598–600. pmid:8102726
- 47. Jackson MJ, Bindoff LA, Weber K, Wilson JN, Ince P, et al. (1994) Biochemical and molecular studies of mitochondrial function in diabetes insipidus, diabetes mellitus, optic atrophy, and deafness. Diabetes Care 17: 728–733. pmid:7924787
- 48. Pilz D, Quarrell OW, Jones EW (1994) Mitochondrial mutation commonly associated with Leber's hereditary optic neuropathy observed in a patient with Wolfram syndrome (DIDMOAD). J Med Genet 31: 328–330. pmid:8071960
- 49. Cagalinec M, Liiv M, Hodurova Z, Hickey MA, Vaarmann A, et al. (2016) Role of Mitochondrial Dynamics in Neuronal Development: Mechanism for Wolfram Syndrome. PLoS Biol 14: e1002511. pmid:27434582
- 50. Hardingham GE, Bading H (2010) Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci 11: 682–696. pmid:20842175
- 51. Lewerenz J, Maher P (2015) Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence? Front Neurosci 9: 469. pmid:26733784
- 52. Zemlyak I, Manley N, Vulih-Shultzman I, Cutler AB, Graber K, et al. (2009) The microtubule interacting drug candidate NAP protects against kainic acid toxicity in a rat model of epilepsy. J Neurochem 111: 1252–1263. pmid:19799711
- 53. Leal SM, Neckameyer WS (2002) Pharmacological evidence for GABAergic regulation of specific behaviors in Drosophila melanogaster. J Neurobiol 50: 245–261. pmid:11810639
- 54. Rival T, Soustelle L, Strambi C, Besson MT, Iche M, et al. (2004) Decreasing glutamate buffering capacity triggers oxidative stress and neuropil degeneration in the Drosophila brain. Curr Biol 14: 599–605. pmid:15062101
- 55. Stacey SM, Muraro NI, Peco E, Labbe A, Thomas GB, et al. (2010) Drosophila glial glutamate transporter Eaat1 is regulated by fringe-mediated notch signaling and is essential for larval locomotion. J Neurosci 30: 14446–14457. pmid:20980602
- 56. Genis D, Davalos A, Molins A, Ferrer I (1997) Wolfram syndrome: a neuropathological study. Acta Neuropathol 93: 426–429. pmid:9113209
- 57. Hilson JB, Merchant SN, Adams JC, Joseph JT (2009) Wolfram syndrome: a clinicopathologic correlation. Acta Neuropathol 118: 415–428. pmid:19449020
- 58. Shannon P, Becker L, Deck J (1999) Evidence of widespread axonal pathology in Wolfram syndrome. Acta Neuropathol 98: 304–308. pmid:10483789
- 59. Ando K, Maruko-Otake A, Ohtake Y, Hayashishita M, Sekiya M, et al. (2016) Stabilization of Microtubule-Unbound Tau via Tau Phosphorylation at Ser262/356 by Par-1/MARK Contributes to Augmentation of AD-Related Phosphorylation and Abeta42-Induced Tau Toxicity. PLoS Genet 12: e1005917. pmid:27023670
- 60. Gharanei S, Zatyka M, Astuti D, Fenton J, Sik A, et al. (2013) Vacuolar-type H+-ATPase V1A subunit is a molecular partner of Wolfram syndrome 1 (WFS1) protein, which regulates its expression and stability. Hum Mol Genet 22: 203–217. pmid:23035048
- 61. Gabreels BA, Swaab DF, de Kleijn DP, Dean A, Seidah NG, et al. (1998) The vasopressin precursor is not processed in the hypothalamus of Wolfram syndrome patients with diabetes insipidus: evidence for the involvement of PC2 and 7B2. J Clin Endocrinol Metab 83: 4026–4033. pmid:9814487
- 62. Palgi M, Lindstrom R, Peranen J, Piepponen TP, Saarma M, et al. (2009) Evidence that DmMANF is an invertebrate neurotrophic factor supporting dopaminergic neurons. Proc Natl Acad Sci U S A 106: 2429–2434. pmid:19164766
- 63. Iijima K, Liu HP, Chiang AS, Hearn SA, Konsolaki M, et al. (2004) Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer's disease. Proc Natl Acad Sci U S A 101: 6623–6628. pmid:15069204
- 64. Iijima K, Chiang HC, Hearn SA, Hakker I, Gatt A, et al. (2008) Abeta42 mutants with different aggregation profiles induce distinct pathologies in Drosophila. PLoS One 3: e1703. pmid:18301778
- 65. Iijima-Ando K, Hearn SA, Shenton C, Gatt A, Zhao L, et al. (2009) Mitochondrial mislocalization underlies Abeta42-induced neuronal dysfunction in a Drosophila model of Alzheimer's disease. PLoS One 4: e8310. pmid:20016833